GTJA Investment Group: Funding, Team & Investors | Startup Intros

Loading organizations...

GTJA Investment Group: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 16, 2025	BridGene Biosciences	$28.0M Series B	Yuexing Su	Grains Valley Venture Capital, Lapam Capital, Proxima Ventures
Jan 5, 2022	Atom Bioscience & Pharmaceutical	$45.0M Series C	Yuhang Teng, Huang Pu	Efung Capital, Hongshan Capital Group (Sequoia Capital China), Kaitai Capital, Livzon Pharmaceutical Group, Unifortune Investment Holdings Group
Jul 1, 2020	Harbour Biomed	$100.0M Series C	Jo-Wen Lin	OrbiMed, AEF Greater Bay Area Fund, Country Garden Venture Capital, Octagon Capital, Sage Partners
Jan 21, 2020	Lachesis	$21.8M Series B	GTJA Investment Group, Shenzhen Capital Group	—
Jan 2, 2020	CF PharmTech	$90.0M Series E	蔡磊	CMB International, CR-CP Life Science Fund, Finnova Capital, Longmen Capital, Oriza Holdings
Sep 4, 2018	Jianke	$130.0M Series B	GTJA Investment Group	Crescent Point, HBM Healthcare Investments
Apr 24, 2018	Innovative Cellular Therapeutics	$25.2M Other Equity	—	（刘缨） Helena Liu, Suyang Zhang
Nov 3, 2017	Annoroad	$105.0M Series C	GTJA Investment Group, Ping An Ventures	SAIF Partners, SBCVC
Sep 12, 2017	Wellem	$30.0M Series B	GTJA Investment Group	—
Aug 29, 2017	Akeso Biopharma	$45.5M Series B	GTJA Investment Group	Shenzhen Capital Group
Jan 25, 2017	Mabworks	$39.0M Series B	GTJA Investment Group	—